Cabaletta Bio, Inc.
CABA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001759138
No open-market purchases or sales by Cabaletta Bio, Inc. insiders were filed in the last 90 days; 139 institutions reported holding it in 13F filings for Q2 2026, worth $490.4M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Cabaletta Bio, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 159
- +31 vs. Q4 2023
- Shares held
- 51.1M
- +2.51M (+5.2%) vs. Q4 2023
- Total value
- $870.9M
- −$230.9M (−21.0%) vs. Q4 2023
- New holders
- 46
- 46 more added
- Sold out
- 15
- 47 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CABA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 139 | $490.4M |
| Q1 2026 | 108 | $227.5M |
| Q4 2025 | 95 | $166.9M |
| Q3 2025 | 75 | $162.0M |
| Q2 2025 | 86 | $110.7M |
| Q1 2025 | 93 | $50.3M |
| Q4 2024 | 109 | $87.2M |
| Q3 2024 | 120 | $226.7M |
| Q2 2024 | 142 | $380.0M |
| Q1 2024 | 159 | $870.9M |
| Q4 2023 | 128 | $1.10B |
| Q3 2023 | 97 | $622.6M |
| Q2 2023 | 84 | $470.5M |
| Q1 2023 | 72 | $203.9M |
| Q4 2022 | 61 | $183.9M |
| Q3 2022 | 54 | $7.76M |
| Q2 2022 | 55 | $17.8M |
| Q1 2022 | 62 | $36.9M |
| Q4 2021 | 66 | $68.9M |
| Q3 2021 | 61 | $211.3M |
| Q2 2021 | 63 | $135.5M |
| Q1 2021 | 68 | $180.1M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Cabaletta Bio, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Westwood Holdings Group Inc. | 82,228 | $1.40M | 0.01% | +82,228 | New |
| New York State Common Retirement Fund | 82,386 | $1.41M | 0.00% | +57,195+227.0% | Added |
| Crestline Management, LP | 85,000 | $1.45M | 0.14% | +85,000 | New |
| TCG Crossover Management, LLC | 86,795 | $1.48M | 0.12% | −400,000−82.2% | Reduced |
| Charles Schwab Investment Management Inc | 93,525 | $1.60M | 0.00% | −2,785−2.9% | Reduced |
| TD Asset Management Inc | 127,030 | $2.17M | 0.00% | +33,400+35.7% | Added |
| Cubist Systematic Strategies, LLC | 137,538 | $2.35M | 0.03% | +108,297+370.4% | Added |
| Bank of New York Mellon Corp | 146,061 | $2.49M | 0.00% | −10,892−6.9% | Reduced |
| Cutter Capital Management, LP | 157,964 | $2.69M | 1.04% | −72,036−31.3% | Reduced |
| Caption Management, LLC | 160,000 | $2.73M | 0.30% | +121,700+317.8% | Added |
| Neuberger Berman Group LLC | 164,605 | $2.81M | 0.00% | +164,605 | New |
| Marshall Wace, LLP | 171,187 | $2.92M | 0.00% | +171,187 | New |
| Saturn V Capital Management LLC | 173,173 | $2.95M | 1.18% | +173,173 | New |
| AXA S.A. | 178,162 | $3.04M | 0.01% | +178,162 | New |
| Nuveen Asset Management, LLC | 198,037 | $3.38M | 0.00% | −43,750−18.1% | Reduced |
| Candriam Luxembourg S.C.A. | 200,000 | $3.41M | 0.02% | +200,000 | New |
| UBS Group AG | 209,476 | $3.57M | 0.00% | +70,831+51.1% | Added |
| Bank of America Corp | 238,103 | $4.06M | 0.00% | +77,583+48.3% | Added |
| Woodline Partners LP | 242,663 | $4.14M | 0.04% | +1,210+0.5% | Added |
| Voloridge Investment Management, LLC | 278,123 | $4.74M | 0.02% | +41,723+17.6% | Added |
| Point72 Asset Management, L.P. | 282,651 | $4.82M | 0.01% | −2,015−0.7% | Reduced |
| Superstring Capital Management LP | 290,797 | $4.96M | 3.28% | +290,797 | New |
| Citigroup Inc | 301,886 | $5.15M | 0.01% | +215,340+248.8% | Added |
| Northern Trust Corp | 304,161 | $5.19M | 0.00% | −6,511−2.1% | Reduced |
| Schonfeld Strategic Advisors LLC | 317,520 | $5.42M | 0.04% | +65,905+26.2% | Added |
| Ensign Peak Advisors, Inc | 330,925 | $5.65M | 0.01% | +212,923+180.4% | Added |
| Artisan Partners Limited Partnership | 334,813 | $5.71M | 0.01% | +334,813 | New |
| Rafferty Asset Management, LLC | 354,424 | $6.05M | 0.02% | +145,161+69.4% | Added |
| Victory Capital Management Inc | 371,623 | $6.34M | 0.01% | −32,304−8.0% | Reduced |
| Ghost Tree Capital, LLC | 375,000 | $6.40M | 2.06% | +225,000+150.0% | Added |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 417,000 | $7.11M | 0.19% | +417,000 | New |
| Integral Health Asset Management, LLC | 425,000 | $7.25M | 0.71% | −95,000−18.3% | Reduced |
| Goldman Sachs Group Inc | 425,174 | $7.25M | 0.00% | +187,037+78.5% | Added |
| Sofinnova Investments, Inc. | 429,746 | $7.33M | 0.43% | +351+0.1% | Added |
| Qube Research & Technologies Ltd | 434,500 | $7.41M | 0.01% | +382,301+732.4% | Added |
| Redmile Group, LLC | 442,826 | $7.55M | 0.28% | −931,363−67.8% | Reduced |
| Millennium Management LLC | 459,367 | $7.84M | 0.01% | +459,367 | New |
| Alkeon Capital Management LLC | 500,000 | $8.53M | 0.05% | +140,000+38.9% | Added |
| Price T Rowe Associates Inc | 612,398 | $10.4M | 0.00% | +84,633+16.0% | Added |
| Invesco Ltd. | 744,777 | $12.7M | 0.00% | −653,165−46.7% | Reduced |
| Geode Capital Management, LLC | 773,090 | $13.2M | 0.00% | +19,914+2.6% | Added |
| Morgan Stanley | 885,704 | $15.1M | 0.00% | +498,321+128.6% | Added |
| StemPoint Capital LP | 1,003,916 | $17.1M | 4.58% | +553,210+122.7% | Added |
| Wellington Management Group LLP | 1,008,259 | $17.2M | 0.00% | +468,383+86.8% | Added |
| Commodore Capital LP | 1,100,000 | $18.8M | 1.25% | −800,000−42.1% | Reduced |
| Cormorant Asset Management, LP | 1,100,000 | $18.8M | 0.83% | +1,100,000 | New |
| Polar Capital Holdings Plc | 1,250,000 | $21.3M | 0.13% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 1,258,650 | $21.5M | 0.37% | −749,079−37.3% | Reduced |
| VR Adviser, LLC | 1,563,952 | $26.7M | 1.27% | −1,000,000−39.0% | Reduced |
| Bain Capital Life Sciences Investors, LLC | 1,617,364 | $27.6M | 2.22% | −382,636−19.1% | Reduced |
| Perceptive Advisors LLC | 1,716,660 | $29.3M | 0.52% | −286,398−14.3% | Reduced |
| Lynx1 Capital Management LP | 2,082,973 | $35.5M | 9.15% | −27,428−1.3% | Reduced |
| Vanguard Group Inc | 2,276,222 | $38.8M | 0.00% | +144,291+6.8% | Added |
| T. Rowe Price Investment Management, Inc. | 2,470,493 | $42.1M | 0.03% | +637,639+34.8% | Added |
| Adage Capital Partners GP, L.L.C. | 3,036,645 | $51.8M | 0.10% | −230,000−7.0% | Reduced |
| Fred Alger Management, LLC | 3,110,314 | $53.1M | 0.26% | −216,818−6.5% | Reduced |
| Jennison Associates LLC | 3,422,984 | $58.4M | 0.04% | +1,796,356+110.4% | Added |
| State Street Corp | 3,741,460 | $63.8M | 0.00% | +1,146,990+44.2% | Added |
| BlackRock Inc. | 4,057,113 | $69.2M | 0.00% | −351,892−8.0% | Reduced |
| Holocene Advisors, LP | 0 | $0 | 0.00% | −1,920,323−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −216,620−100.0% | Sold out |
| First Turn Management, LLC | 0 | $0 | 0.00% | −175,359−100.0% | Sold out |
| Rokos Capital Management LLP | 0 | $0 | 0.00% | −80,335−100.0% | Sold out |
| Nicholas Investment Partners, LP | 0 | $0 | 0.00% | −54,586−100.0% | Sold out |
| Exome Asset Management LLC | 0 | $0 | 0.00% | −46,700−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −46,021−100.0% | Sold out |
| Advisory Research Inc | 0 | $0 | 0.00% | −17,660−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −13,958−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −11,100−100.0% | Sold out |
| State Board of Administration of Florida Retirement System | 0 | $0 | 0.00% | −9,830−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −9,740−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −3,397−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −1,164−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −132−100.0% | Sold out |